We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Changes in recommended treatments for mild and moderate asthma.
- Authors
Redding, Gregory J.; Stoloff, Stuart W.
- Abstract
This article reviews the 2002 National Asthma Education and Prevention Program (NAEPP) recommendations for the use of controlled medications for asthma, including the relative effectiveness of inhaled corticosteroids (ICSs) versus other controller medications, safety of long-term ICS use in children, and potential benefits of early ICS treatment. Observations include: that every patient with persistent asthma should use a daily controller medication; the need to consider an ICS first when choosing controller medication; that leukotriene modifiers, cromolyn and nedocromil may be considered as alternatives; that long-acting β2-adrenergic agonists should not be used as monotherapy; that long-term use of ICS within labeled doses is safe for children; that low- to medium-dose ICSs are not associated with the development of cataracts or glaucoma in children, but high cumulative lifetime doses may slightly increase the prevalence of cataracts in adults and elderly patients; and that ICSs are recommended for use in pregnant women with asthma.
- Subjects
ASTHMA treatment; OBSTRUCTIVE lung disease treatment; ASTHMA in children; HORMONE therapy; ADRENOCORTICAL hormones; LEUKOTRIENES; ADRENERGIC beta agonists
- Publication
Journal of Family Practice, 2004, Vol 53, Issue 9, p692
- ISSN
0094-3509
- Publication type
Article